ADAM17 and gastric cancer: The progression of gastric cancer correlates with the expression of ADAM10 and ADAM17 and high ADAM10/ADAM17 expression levels were associated with patient’s poor prognosis [58,59] and the establishment of lymph node metastasis [73].